Tag

AstraZeneca

AstraZeneca announces large-scale initiatives in China to advance global medicine R&D

November 6, 2019

AstraZeneca has announced three large-scale …

AstraZeneca divests rights to Seroquel and Seroquel XR in Europe and Russia

November 5, 2019

AstraZeneca has agreed the sale …

AstraZeneca commits $35 million to non-communicable diseases

October 23, 2019

The company will extend funding …

AstraZeneca’s Farxiga approved in the US to reduce the risk of hospitalisation for heart failure in patients with type-2 diabetes

October 21, 2019

The US Food and Drug …

AstraZeneca’s Fasenra approved in the US for self-administration in a new pre-filled auto-injector

October 8, 2019

The US Food and Drug …

AstraZeneca divests rights for Losec to Cheplapharm

October 1, 2019

AstraZeneca has agreed to sell …

AstraZeneca scientist

Nanoform and AstraZeneca initiate technology evaluation

September 25, 2019

Nanoform has announced the initiation …

AstraZeneca research

AstraZeneca’s Qtrilmet recommended for approval in EU by CHMP for the treatment of type-2 diabetes

September 24, 2019

The company has announced that …

Fast Track designation for AstraZeneca’s Farxiga

September 16, 2019

TheUS Food and Drug Administration …

New results from AstraZeneca’s Imfinzi trial

September 10, 2019

The company has presented detailed …

David Fredrickson

AstraZeneca’s Tagrisso approved in China as a 1st-line treatment for EGFR-mutated non-small cell lung cancer

September 4, 2019

The company has received marketing …

Mene Pangalos

FDA grants Fast Track designation for AstraZeneca’s Farxiga

August 28, 2019

The US Food and Drug …

Sobi Research

Sobi sells Priority Review Voucher to AstraZeneca

August 22, 2019

Swedish Orphan Biovitrum has entered …

AstraZeneca research

AstraZeneca’s Calquence granted Breakthrough Therapy Designation in the US

August 14, 2019

The US Food and Drug …

Positive results about AstraZeneca’s Tagrisso

August 12, 2019

The company has announced positive …

AstraZeneca’s PAOLA-1 trial met primary endpoint

August 8, 2019

AstraZeneca and MSD have announced …

1
2
3
···
15